Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)

NCT06519097 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Neoplasm of Pancreas
IPMN, Pancreatic

Interventions

DRUG: Vitamin E Delta Tocotrienol
OTHER: Placebo

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]